Cytokinetics Inc (NASDAQ: CYTK), a South San Francisco, California, company, fell to close at $29.52 Friday after losing $0.53 (1.76%) on volume of 843,683 shares. The stock ranged from a high of $30.53 to a low of $29.40 while Cytokinetics’s market cap now stands at $2,465,294,018.
About Cytokinetics Inc
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.